Number of isolates tested for ceftriaxone in Latvia
Latvia: Number of isolates tested for ceftriaxone was 7 in 2019. ◆ Volatile
Latest (2019)
7
Change on year
up 40.0%
World rank
50th
of 52 countries
All-time high
39
in 2012
All-time low
4
in 2017
Years of data
10
2009–2019
Number of isolates tested for ceftriaxone in Latvia, 2009–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, number of isolates tested for ceftriaxone in Latvia stood at 7.
The figure is up 40.0% on the previous year and down 22.2% over ten years.
Over the whole period, number of isolates tested for ceftriaxone in Latvia peaked at 39 in 2012 and was at its lowest, 4, in 2017.
That places Latvia 50th out of 52 countries with data for 2019, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Number of isolates tested for ceftriaxone in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 9 | — |
| 2010 | 20 | +122.2% |
| 2011 | 28 | +40.0% |
| 2012 | 39 | +39.3% |
| 2013 | 38 | -2.6% |
| 2015 | 9 | -76.3% |
| 2016 | 8 | -11.1% |
| 2017 | 4 | -50.0% |
| 2018 | 5 | +25.0% |
| 2019 | 7 | +40.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9 | 9 | 9 | 1 |
| 2010s | 17.56 | 4 | 39 | 9 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Heat deaths vs projected death rates 1,593 (2090)
- Un projection of annual infant deaths 4 (2100)
- Population ages 0-14, female, annual growth rate -2.48 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0733 units per person (2025)
- Population ages 0-14, male, annual growth rate -2.39 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0786 units per person (2025)
Frequently asked questions
- What is number of isolates tested for ceftriaxone in Latvia?
- Number of isolates tested for ceftriaxone in Latvia was 7 in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest number of isolates tested for ceftriaxone recorded in Latvia?
- The highest recorded value was 39 in 2012.
- What is the lowest number of isolates tested for ceftriaxone recorded in Latvia?
- The lowest recorded value was 4 in 2017.
- How does Latvia rank for number of isolates tested for ceftriaxone?
- Latvia ranks 50th out of 52 countries with data for 2019.
- Is number of isolates tested for ceftriaxone rising or falling in Latvia?
- Over the last ten years it is down 22.2%. The long-run trend across the full record is volatile.
- Where does this Latvia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Number of isolates tested for ceftriaxone. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).